Clinical Trial Update: A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating GW677954 in combination with insulin for type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GW677954
• Insulin (insulin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2 | Phase 2 | Status: TERMINATED